GCLC Antikörper (AA 286-315)
-
- Target Alle GCLC Antikörper anzeigen
- GCLC (Glutamate-Cysteine Ligase, Catalytic Subunit (GCLC))
-
Bindungsspezifität
- AA 286-315
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GCLC Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Kreuzreaktivität (Details)
- Expected species reactivity: Rat
- Aufreinigung
- Antigen affinity purified
- Immunogen
- A portion of amino acids 286-315 from the human protein was used as the immunogen for this GCLC antibody.
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product GCLC Primärantikörper
-
-
- Applikationshinweise
- Titration of the GCLC antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot the GCLC antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
- Target
- GCLC (Glutamate-Cysteine Ligase, Catalytic Subunit (GCLC))
- Andere Bezeichnung
- GCLC (GCLC Produkte)
- Hintergrund
- Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase is the first rate-limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subunit and a light regulatory subunit. This locus encodes the catalytic subunit, while the regulatory subunit is derived from a different gene located on chromosome 1p22-p21. Mutations at this locus have been associated with hemolytic anemia due to deficiency of gamma-glutamylcysteine synthetase and susceptibility to myocardial infarction.
- UniProt
- P48506
- Pathways
- Cell RedoxHomeostasis
-